Blockchain Registration Transaction Record

Lantern Pharma to Demonstrate withZeta.ai AI Co-Scientist Platform Live

Lantern Pharma to host live demo of withZeta.ai AI co-scientist platform on April 30, 2026. CEO Panna Sharma to showcase AI-driven oncology drug discovery workflows.

This news matters because Lantern Pharma’s withZeta.ai platform represents a leap forward in AI-driven oncology drug discovery. By integrating multi-agentic AI with clinical and molecular data, the platform aims to drastically shorten the timeline for developing treatments for rare cancers—an area often neglected due to high costs and low patient populations. For patients, this could mean faster access to life-saving therapies. For investors, the subscription-based model opens a new revenue stream, potentially boosting the company’s valuation. The live demonstration on April 30, 2026, offers a rare opportunity to see cutting-edge AI in action, validating the technology’s real-world applicability.